These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 12476347)

  • 21. The Role of Mast Cells in Alzheimer's Disease.
    Shaik-Dasthagirisaheb YB; Conti P
    Adv Clin Exp Med; 2016; 25(4):781-7. PubMed ID: 27629855
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of neuroimmunomodulation in Alzheimer's disease.
    Maccioni RB; Rojo LE; Fernández JA; Kuljis RO
    Ann N Y Acad Sci; 2009 Feb; 1153():240-6. PubMed ID: 19236346
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic Brain Inflammation: The Neurochemical Basis for Drugs to Reduce Inflammation.
    Jarrott B; Williams SJ
    Neurochem Res; 2016 Mar; 41(3):523-33. PubMed ID: 26177578
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of inflammation in Alzheimer's disease pathogenesis and therapeutic potential of anti-inflammatory agents.
    Shadfar S; Hwang CJ; Lim MS; Choi DY; Hong JT
    Arch Pharm Res; 2015 Dec; 38(12):2106-19. PubMed ID: 26289122
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pro-inflammatory cytokines in Alzheimer's disease].
    Stamouli EC; Politis AM
    Psychiatriki; 2016; 27(4):264-275. PubMed ID: 28114090
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brain inflammation in Alzheimer disease and the therapeutic implications.
    McGeer EG; McGeer PL
    Curr Pharm Des; 1999 Oct; 5(10):821-36. PubMed ID: 10526088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroinflammatory perspectives on the two faces of Alzheimer's disease.
    Eikelenboom P; van Gool WA
    J Neural Transm (Vienna); 2004 Mar; 111(3):281-94. PubMed ID: 14991455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular aspects of inflammatory and immune responses in Alzheimer's disease.
    Kalaria RN; Harshbarger-Kelly M; Cohen DL; Premkumar DR
    Neurobiol Aging; 1996; 17(5):687-93. PubMed ID: 8892341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Innate immunity and brain inflammation: the key role of complement.
    Francis K; van Beek J; Canova C; Neal JW; Gasque P
    Expert Rev Mol Med; 2003 May; 5(15):1-19. PubMed ID: 14585169
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inflammation and the degenerative diseases of aging.
    McGeer PL; McGeer EG
    Ann N Y Acad Sci; 2004 Dec; 1035():104-16. PubMed ID: 15681803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The possible suppression of Alzheimer's disease by nonsteroidal anti-inflammatory drugs].
    de Jong D; Jansen RW; Verbeek MM; Kremer HP
    Ned Tijdschr Geneeskd; 2002 Nov; 146(44):2074-8. PubMed ID: 12448960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inflammation, immunity, and Alzheimer's disease.
    Town T
    CNS Neurol Disord Drug Targets; 2010 Apr; 9(2):129-31. PubMed ID: 20205648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The brain as a target for inflammatory processes and neuroprotective strategies.
    Skaper SD
    Ann N Y Acad Sci; 2007 Dec; 1122():23-34. PubMed ID: 18077562
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuroinflammation in Alzheimer's disease: Pleiotropic roles for cytokines and neuronal pentraxins.
    Swanson A; Wolf T; Sitzmann A; Willette AA
    Behav Brain Res; 2018 Jul; 347():49-56. PubMed ID: 29462653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The role of inflammatory reaction in Alzheimer's disease and neurodegenerative processes].
    Członkowska A; Kurkowska-Jastrzebska I
    Neurol Neurochir Pol; 2002; 36(1):15-23. PubMed ID: 12053606
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Neuroinflammation as motor of Alzheimer's disease].
    Castro-Gomez S; Binder J; Heneka MT
    Nervenarzt; 2019 Sep; 90(9):898-906. PubMed ID: 31428829
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cannabinoid receptor 2 deficiency results in reduced neuroinflammation in an Alzheimer's disease mouse model.
    Schmöle AC; Lundt R; Ternes S; Albayram Ö; Ulas T; Schultze JL; Bano D; Nicotera P; Alferink J; Zimmer A
    Neurobiol Aging; 2015 Feb; 36(2):710-9. PubMed ID: 25443294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gamma subunit of complement component 8 is a neuroinflammation inhibitor.
    Kim JH; Afridi R; Han J; Jung HG; Kim SC; Hwang EM; Shim HS; Ryu H; Choe Y; Hoe HS; Suk K
    Brain; 2021 Mar; 144(2):528-552. PubMed ID: 33382892
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alterations in immune cells and mediators in the brain: it's not always neuroinflammation!
    Estes ML; McAllister AK
    Brain Pathol; 2014 Nov; 24(6):623-30. PubMed ID: 25345893
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin-18, from neuroinflammation to Alzheimer's disease.
    Bossù P; Ciaramella A; Salani F; Vanni D; Palladino I; Caltagirone C; Scapigliati G
    Curr Pharm Des; 2010; 16(38):4213-24. PubMed ID: 21184660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.